Jordi Xiol

Direktor/Vorstandsmitglied bei

NorthSea Therapeutics BV

Consumer Services

Health Technology

Finance

Profil

Jordi Xiol is currently a Partner at Ysios Capital Partners SGEIC SA since 2019.
He is also a Board Member at NorthSea Therapeutics BV since 2021 and at SpliceBio SL since 2023.
Mr. Xiol completed his undergraduate degree at the University of Barcelona in 2007 and obtained a doctorate from The European Molecular Biology Laboratory.

Aktive Positionen von Jordi Xiol

Unternehmen	Position	Beginn
Ysios Capital Partners SGEIC SA Ysios Capital Partners SGEIC SA Investment ManagersFinance Ysios Capital invests in companies located across the globe. The firm targets companies operating in the fields of the biotechnology sector. It provides financing for early and growth stage capital requirements.	Private Equity Investor	01.06.2021
SpliceBio SL SpliceBio SL BiotechnologyHealth Technology Engages in research and development in biotechnology	Direktor/Vorstandsmitglied	01.01.2023
NorthSea Therapeutics BV NorthSea Therapeutics BV BiotechnologyHealth Technology Operates as a clinical stage biotechnology company that develops novel strategies for the treatment of metabolic, inflammatory and fibrotic diseases	Direktor/Vorstandsmitglied	01.12.2021

Alle aktiven Positionen von Jordi Xiol

Ausbildung von Jordi Xiol

Erfahrungen
Besetzte Positionen

Aktive

Inaktive

Börsennotierte Unternehmen

Private Unternehmen

Sehen Sie sich die Erfahrung von Jordi Xiol im Detail an

Beziehungen

Beziehungen ersten Grades

Unternehmen ersten Grades

Herr

Frau

Aufsichtsräte

Führungskräfte

Sehen Sie sich das persönliche Netzwerk an

Unternehmensverbindungen

Private Unternehmen	5
University of Barcelona University of Barcelona Other Consumer ServicesConsumer Services Functions as a College/University	Consumer Services
The European Molecular Biology Laboratory The European Molecular Biology Laboratory Other Consumer ServicesConsumer Services Functions as a College/University	Consumer Services
Ysios Capital Partners SGEIC SA Ysios Capital Partners SGEIC SA Investment ManagersFinance Ysios Capital invests in companies located across the globe. The firm targets companies operating in the fields of the biotechnology sector. It provides financing for early and growth stage capital requirements.	Finance
NorthSea Therapeutics BV NorthSea Therapeutics BV BiotechnologyHealth Technology Operates as a clinical stage biotechnology company that develops novel strategies for the treatment of metabolic, inflammatory and fibrotic diseases	Health Technology
SpliceBio SL SpliceBio SL BiotechnologyHealth Technology Engages in research and development in biotechnology	Health Technology